Skip to main content
. 2023 May 2;14:1106490. doi: 10.3389/fimmu.2023.1106490

Figure 1.

Figure 1

Clinical phenotype and disease course in patients with anti-GFAP antibodies. (A) Pediatric patients’ clinical phenotype and disease course. (B) Adult patients’ clinical phenotype and disease course.